Compugen (CGEN) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St set to open lower as oil, bond yields tick up
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Compugen Reports Second Quarter 2022 Results
August 4, 2022 7:00 AM EDTPrioritized two indications, MSS-CRC and NSCLC, utilizing fully owned assets, COM701 and COM902Focus on MSS-CRC and NSCLCÂ expected to provide highest probability of success and support future path to registrationFocused development plan results in strategic decision to wind down Phase 1 cohort expansion studies resulting in the conclusion of collaboration with Bristol Myers SquibbMost advanced preclinical program with first-in-class potential entering pre-IND enabling studiesExtended cash runway expected to last through the end of 2024
HOLON, Israel, Aug. 4, 2022 /PRNewswire/ --... More
